Browsing by Author "Bekaii-Saab, Tanios S"
Now showing items 1-3 of 3
-
FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements
Bekaii-Saab, Tanios S; Valle, Juan W; Van Cutsem, Eric; Rimassa, Lorenza; Furuse, Junji; Ioka, Tatsuya; Macarulla Mercadé, Teresa (Future Medicine, 2020-10) -
Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial
Bekaii-Saab, Tanios S; Okusaka, Takuji; Goldstein, David; Ueno, Makoto; Ioka, Tatsuya; Tabernero Caturla, Josep; Oh, Do-Youn (Elsevier, 2023-04) -
Population pharmacokinetics of liposomal irinotecan in patients with cancer and exposure–safety analyses in patients with metastatic pancreatic cancer
Brendel, Karl; Bekaii-Saab, Tanios S; Boland, Patrick M; Dayyani, Farshid; Macarulla Mercadé, Teresa; Dean, Andrew (Wiley, 2021-12)